Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
59.63
+0.89 (1.52%)
At close: Oct 3, 2025, 4:00 PM EDT
59.80
+0.17 (0.29%)
After-hours: Oct 3, 2025, 7:59 PM EDT
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Jun 30, 2025 | 22.12B | 330.77M |
| Mar 31, 2025 | 21.18B | 84.26M |
| Dec 31, 2024 | 20.08B | 97.47M |
| Sep 30, 2024 | 18.50B | 103.92M |
| Jun 30, 2024 | 17.44B | 79.23M |
| Mar 31, 2024 | 16.77B | 429.97M |
| Dec 31, 2023 | 15.66B | 463.92M |
| Sep 30, 2023 | 14.24B | 364.57M |
| Jun 30, 2023 | 12.89B | 652.89M |
| Mar 31, 2023 | 11.82B | 863.08M |
| Dec 31, 2022 | 10.60B | 1.17B |
| Sep 30, 2022 | 9.79B | 1.43B |
| Jun 30, 2022 | 8.99B | 1.46B |
| Mar 31, 2022 | 8.40B | 1.47B |
| Dec 31, 2021 | 7.79B | 1.43B |
| Sep 30, 2021 | 7.35B | 1.48B |
| Jun 30, 2021 | 6.84B | 1.61B |
| Mar 31, 2021 | 6.72B | 1.58B |
| Dec 31, 2020 | 6.88B | 1.63B |
| Sep 30, 2020 | 6.86B | 1.76B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.